Top Suppliers:I want be here


13933-32-9

13933-32-9 structure
13933-32-9 structure
  • Name: Tetraammineplatinum(II) chloride hydrate
  • Chemical Name: Tetraammineplatinum(II) chloride hydrate
  • CAS Number: 13933-32-9
  • Molecular Formula: Cl2H12N4Pt
  • Molecular Weight: 334.10600
  • Create Date: 2018-08-17 11:34:31
  • Modify Date: 2024-01-11 16:46:00

Name Tetraammineplatinum(II) chloride hydrate
Synonyms PLATINUM TETRAAMINO DICHLORIDE
tetrammineplatinous chloride
EINECS 237-706-5
Tetraammineplatinum chloride hydrate
PLATINUM TETRAAMINOCHLORIDE
Tetraammineplatinum chloride
tetraammineplatinumdichloride
Tetraammineplatinum(II) Chloride
Tetraammineplatinous chloride
MFCD00011475
Melting Point 250(分解温度)
Molecular Formula Cl2H12N4Pt
Molecular Weight 334.10600
Exact Mass 333.00900
PSA 12.96000
LogP 2.67210

Section 1: Product Identification
Chemical Name:Tetraammineplatinum (II) chloride monohydrate, 99% (99.95%-Pt)
CAS Registry Number:13933-32-9
Formula:[Pt(NH3)4]Cl2.H2O
EINECS Number:237-706-5
Chemical Family:metal-ammine complexes
Synonym:Platinum(2+), tetraammine-, dichloride, (SP-4-1)-,

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound13933-32-9100%0.002mg/m3(as-Pt)0.002mg/m3(as-Pt)

Section 3: Hazards Identification
Exposure to platinum compounds has been shown to cause wheezing, coughing, and running of the nose.
Emergency Overview:
Skin contact can lead to dermatitis.
Primary Routes of Exposure:Ingestion, inhalation, skin
Eye Contact:Causes mild to moderate irritation of the eyes.
Skin Contact:Causes slight to mild irritation of the skin.
Inhalation:Inhalation of the dust may cause wheezing, coughing, shortness of breath.
Ingestion:Ingestion may lead to dizziness, abdominal cramps, vomiting, bloody diarrhea, weakness, and convulsions.
Irritating to skin, eyes and respiratory tract. Exposure to platinum compounds may lead to wheezing, coughing,
Acute Health Affects:
and running of the nose. Skin exposure may lead to dermatitis.
Chronic Health Affects:No information available on long-term chronic effects.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:not applicable
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:carbon dioxide, foam or dry powder
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self- contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit toxic and corrosive fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Small spills can be mixed with vermiculite, sodium carbonate or other suitable non combustible adsorbent and
Spill and Leak Procedures:
swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a cool, dry place in a tightly sealed container.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves.
Ventilation:To minimize exposure, handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:To minimize exposure, handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:white xtl.
Molecular Weight:334.09 (352.12)
Melting Point:no data
Boiling Point:no data
Vapor Pressure:no data
Specific Gravity:no data
Odor:none
Solubility in Water:Very soluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:active metals
Decomposition Products:ammonium chloride, nitrogen oxides, and platinum salts.

SECTION 11: Toxicological Information
RTECS Data:Mutation in microorganisms(bacteria); Salmonella typhimurium: 500ug/plate
Carcinogenic Effects:No data
Mutagenic Effects:Insufficient data
Tetratogenic Effects:No data

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Listed in the TSCA inventory.
SARA (Title 313):Not regulated by Title 313.
Second Ingredient:None


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TP2507150
CHEMICAL NAME :
Platinum(II), tetraammine-, dichloride
CAS REGISTRY NUMBER :
13933-32-9
LAST UPDATED :
199701
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
Cl2-H12-N4-Pt
MOLECULAR WEIGHT :
334.15

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

TYPE OF TEST :
Phage inhibition capacity
TEST SYSTEM :
Bacteria - Escherichia coli
DOSE/DURATION :
50 ug/plate
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 43,2819,1983
Hazard Codes Xn:Harmful;
Risk Phrases R20/21/22;R36/37/38
Safety Phrases S26-S37/39
RTECS TP2507150